SuperworthNeumora Therapeutics market cap NMRA
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $71.3M
- Highest close in our data
- $3B
- Feb 2024
Neumora Therapeutics is worth $71.3M at the close on Oct 23, 2026, at $0.38 a share.
That is down 83% over the last year.
Its highest close in our data was $3B in Feb 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $71.3M | $71.3M | $583.1M | −76% |
| 2025 | $297.4M | $104.8M | $489.1M | −84% |
| 2024 | $1.8B | $1.5B | $3B | −30% |
| 2023 | $2.6B | $1.8B | $2.7B | n/a |
Against its peers
Companies in Healthcare nearest Neumora Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| NMRANeumora Therapeutics | $71.3M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| APTAlpha Pro Tech | $56.7M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NEPHNephros | $38.3M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $83.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Neumora Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.